APA (7th ed.) Citation

OS, K., D, C., & KN, M. (2026). Individualizing Thromboprophylaxis: From Fixed Doses to Targeted Low-Molecular-Weight Heparin Use. Cardiovascular drugs and therapy, 40(3), 1177. https://doi.org/10.1007/s10557-025-07806-x

Chicago Style (17th ed.) Citation

OS, Kotsiou, Charalampidis D, and Malizos KN. "Individualizing Thromboprophylaxis: From Fixed Doses to Targeted Low-Molecular-Weight Heparin Use." Cardiovascular Drugs and Therapy 40, no. 3 (2026): 1177. https://doi.org/10.1007/s10557-025-07806-x.

MLA (9th ed.) Citation

OS, Kotsiou, et al. "Individualizing Thromboprophylaxis: From Fixed Doses to Targeted Low-Molecular-Weight Heparin Use." Cardiovascular Drugs and Therapy, vol. 40, no. 3, 2026, p. 1177, https://doi.org/10.1007/s10557-025-07806-x.